In response to the increasing demand of the industry for the integration of enzymes in internal development programs, c-LEcta has launched the...

During the ongoing year 2010, already the third project jointly executed by c-LEcta and an industrial partner has now entered the commercialization...

c-LEcta announces a license agreement with DSM Pharmaceutical Products, which grants DSM rights to c-LEcta’s proprietary alcohol dehydrogenases for...

During a reception in Dresden the FutureSax prices were awarded in the two categories “best start-up” and “growth”. c-LEcta won the FutureSax award in...

c-LEcta has established a novel production process for the Serratia nuclease enzyme from Serratia marcescens. This new process is based on a...

c-LEcta has relaunched an updated version of its company website. This was done in order to reflect the developments in the past years and the...